ComplianceOnline

India – Supreme Court Rejects Novartis Cancer Drug Patent Application

  • By: Staff Editor
  • Date: March 30, 2013
Webinar All Access Pass Subscription Abstract:

International companies looking to protect their intellectual property in India were dealt a blow today when the country's Supreme Court denied a patent application for a best-selling cancer drug from the Swiss drugmaker Novartis. On the other hand, medical charities and poor countries that depend on generic drugs were cheering the decision.

Bookmark and Share

Trending Compliance Trainings

Best Sellers
You Recently Viewed
    Loading